International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017-Reference-Cited by-同舟云学术

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Published:2018-01 Issue:1 Volume:18 Page:2-11
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Isaji Shuji,Mizuno Shugo,Windsor John A.^ORCID,Bassi Claudio,Fernández-del Castillo Carlos,Hackert Thilo,Hayasaki Aoi,Katz Matthew H.G.,Kim Sun-Whe,Kishiwada Masashi,Kitagawa Hirohisa,Michalski Christoph W.,Wolfgang Christopher L.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Borderline resectable pancreatic cancer: the importance of this emerging stage of dis- ease;Katz;J Am Coll Surg,2008

2. Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC;Kim;J Clin Oncol,2016

3. Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in Oncology trial A021101;Katz;JAMA Surg,2016

4. Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment;Fujii;Med Baltim,2015

5. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival;Rose;Ann Surg Oncol,2014

Cited by 509 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nationwide trends over 10 years in epidemiology and management of pancreatic ductal adenocarcinoma: A real-world study from the French administrative database;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Reassigned surgical margins after neoadjuvant chemotherapy results in low local recurrence in dogs with mast cell tumours;Veterinary Record;2024-09-11

3. Therapie des Pankreaskarzinoms: Innovative Chirurgie und moderne Systemtherapien;Deutsches Ärzteblatt Online;2024-09-06

4. Impact on survival of sarcopenia, systemic inflammatory response and anthropometric factors after pancreatectomy for resectable pancreatic adenocarcinoma;World Journal of Surgical Oncology;2024-09-04

5. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines;Molecular Therapy: Oncology;2024-09